Candidate HIV/AIDS vaccines: lessons learned from the World's first phase III efficacy trials

被引：73

作者：

Francis, DP ^{[1
]}

Heyward, WL ^{[1
]}

Popovic, V ^{[1
]}

Orozco-Cronin, P ^{[1
]}

Orelind, K ^{[1
]}

Gee, C ^{[1
]}

Hirsch, A ^{[1
]}

Ippolito, T ^{[1
]}

Luck, A ^{[1
]}

Longhi, M ^{[1
]}

Gulati, V ^{[1
]}

Winslow, N ^{[1
]}

Gurwith, M ^{[1
]}

Sinangil, F ^{[1
]}

Berman, PW ^{[1
]}

机构：

[1] VaxGen Inc, Brisbane, CA 94005 USA

来源：

AIDS | 2003年 / 17卷 / 02期

关键词：

HIV; candidate vaccine; clinical trial; phase III;

D O I：

10.1097/00002030-200301240-00003

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

[No abstract available]

引用

收藏

页码：147 / 156

页数：10

相关论文

共 19 条

[1] Protection of MN-rgp120-immunized chimpanzees from heterologous infection with a primary isolate of human immunodeficiency virus type 1 [J].

Berman, PW ;

Murthy, KK ;

Wrin, T ;

Vennari, JC ;

Cobb, EK ;

Eastman, DJ ;

Champe, M ;

Nakamura, GR ;

Davison, D ;

Powell, MF ;

Bussiere, J ;

Francis, DP ;

Matthews, T ;

Gregory, TJ ;

Obijeski, JF .

JOURNAL OF INFECTIOUS DISEASES, 1996, 173 (01) :52-59

[2]

Berman PW, 1998, AIDS RES HUM RETROV, V14, pS277

[3] HUMAN IMMUNODEFICIENCY VIRUS TYPE-1 CHALLENGE OF CHIMPANZEES IMMUNIZED WITH RECOMBINANT ENVELOPE GLYCOPROTEIN GP120 [J].

BERMAN, PW ;

GROOPMAN, JE ;

GREGORY, T ;

CLAPHAM, PR ;

WEISS, RA ;

FERRIANI, R ;

RIDDLE, L ;

SHIMASAKI, C ;

LUCAS, C ;

LASKY, LA ;

EICHBERG, JW .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (14) :5200-5204

[4] PROTECTION OF CHIMPANZEES FROM INFECTION BY HIV-1 AFTER VACCINATION WITH RECOMBINANT GLYCOPROTEIN GP120 BUT NOT GP160 [J].

BERMAN, PW ;

GREGORY, TJ ;

RIDDLE, L ;

NAKAMURA, GR ;

CHAMPE, MA ;

PORTER, JP ;

WURM, FM ;

HERSHBERG, RD ;

COBB, EK ;

EICHBERG, JW .

NATURE, 1990, 345 (6276) :622-625

[5] Feasibility of human immunodeficiency virus vaccine trials in homosexual men in the United States: Risk behavior, seroincidence, and willingness to participate [J].

Buchbinder, SP ;

Douglas, JM ;

McKirnan, DJ ;

Judson, FN ;

Katz, MH ;

MacQueen, KM .

JOURNAL OF INFECTIOUS DISEASES, 1996, 174 (05) :954-961

[6]

CHESNEY MA, 1997, J ACQ IMMUN DEF SYND, V16, P206

[7] THE PREVENTION OF HEPATITIS-B WITH VACCINE - REPORT OF THE CENTERS-FOR-DISEASE-CONTROL MULTI-CENTER EFFICACY TRIAL AMONG HOMOSEXUAL MEN [J].

FRANCIS, DP ;

HADLER, SC ;

THOMPSON, SE ;

MAYNARD, JE ;

OSTROW, DG ;

ALTMAN, N ;

BRAFF, EH ;

OMALLEY, P ;

HAWKINS, D ;

JUDSON, FN ;

PENLEY, K ;

NYLUND, T ;

CHRISTIE, G ;

MEYERS, F ;

MOORE, JN ;

GARDNER, A ;

DOTO, IL ;

MILLER, JH ;

REYNOLDS, GH ;

MURPHY, BL ;

SCHABLE, CA ;

CLARK, BT ;

CURRAN, JW ;

REDEKER, AG .

ANNALS OF INTERNAL MEDICINE, 1982, 97 (03) :362-366

[8]

Francis DP, 1998, AIDS RES HUM RETROV, V14, pS325

[9]

Heyward WL, 1998, AIDS RES HUM RETROV, V14, pS205

[10] Recombinant HIV-1 glycoprotein 120 induces distinct types of delayed hypersensitivity in persons with or without pre-existing immunologic memory [J].

Hladik, F ;

Bender, S ;

Akridge, RE ;

Hu, YX ;

Galloway, C ;

Francis, D ;

McElrath, MJ .

JOURNAL OF IMMUNOLOGY, 2001, 166 (05) :3580-3588